Neumann launches survey on clinicians’ attitude towards HPV screening

Neumann prepared this survey to learn what clinicians are thinking about the approaching era of HPV screening as part of cervical cancer prevention and its potential benefits.

The survey gauges clinicians’ attitudes towards the introduction of HPV screening into cervical cancer prevention. HPV screening will bring along fundamental changes in a very important public health program.

Neumann intends to understand better how these changes will impact everyday work. The Pap test has been used for decades and both doctors and patients alike are accustomed to it. Soon it may not be available as a primary screening method. We need to prepare for this transformation.

You may fill in the questionnaire without providing personal data and contact details, however if you do, you will participate in a Veuve Clicquot Champagne Yellow Label giveaway. We will raffle 5 bottles of Champagne amongst participants.

You have to work within the EU to be eligible.

Survey results will be published anonymously.

Click here to participate.